25,405.00

Content Details
Information on this page was last modified on : 2021/05/16 3:17:24 PM

Erlocip tablet 150 mg 30’s

Belongs to Category,

Erlocip tablet contains Erlotinib | belongs to Protein kinase inhibitor

Alternate brands of Erlocip tablet 150 mg 30’s

Brand Name Price Savings
Tarceva tablet 150 mg 30’s  179,220.00 You will pay -153815 more
Tarceva tablet 100 mg 30’s  147,076.00 You will pay -121671 more
Erlocip tablet 100 mg 30’s  20,304.00 You can save 5101
List of alternate brands

How it works

Erlocip tablet 150 mg 30’s works by blocking the action of an abnormal protein that signals cancer cells to multiply. This helps slow or stop the spread of cancer cells.

Side effects

Major & minor side effects for Erlocip tablet 150 mg 30’s

  • Burning or tingling sensation
  • Cough
  • Diarrhea severe
  • Lower back or side pain
  • Rash severe
  • Chills and fever
  • Blurred vision rare
  • Convulsions (seizures) rare
  • Chest pain or discomfort rare
  • Acid or sour stomach
  • Hair loss
  • Loss of appetite

Uses of Erlocip tablet 150 mg 30’s

What is it prescribed for?

  • Non-Small Cell Lung Cancer

    This medicine is used for the treatment of non-small cell lung cancer, a disease characterized by symptoms such as a persistent cough, shortness of breath, weight loss, coughing up blood, etc.

  • Pancreatic Cancer

    This medicine is used in a combination with gemcitabine for the treatment of pancreatic cancer.

Concerns

Frequently asked questions

  • Onset of action

    The amount of time required for this medicine to show its action is not clinically established.

  • Duration of Effect

    The amount of time for which this medicine remains active in the body is not clinically established.

  • Safe with Alchohol?

    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

  • Is it habit forming?

    No habit-forming tendencies were reported.

  • Usage in pregnancy?

    This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

  • Usage while breast-feeding?

    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the medicine based on your clinical condition.

When not to use?

  • Allergy

    This medicine is not recommended for use in patients with a known allergy to Erlocip tablet 150 mg 30’s or any other inactive ingredients present along with this medicine.

Warnings

Warnings for special population
  • Pregnancy

    This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

  • Breast-feeding

    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the medicine based on your clinical condition.

General Warnings
  • Anticoagulants

    This medicine should be used with caution in patients receiving anticoagulants due to the increased risk of excessive bleeding. Close monitoring of INR, appropriate dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

  • Hepatic Impairment

    This medicine should be used with caution in patients suffering from liver diseases due to the increased risk of worsening of the patient's condition. Close monitoring of liver function tests is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

  • Renal Impairment

    This medicine should be used with caution in patients suffering from kidney diseases due to the increased risk of severe adverse effects. Close monitoring of kidney function, appropriate dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition of the patient.

  • Gastrointestinal Perforations

    This medicine should be used with extreme caution in patients suffering from gastrointestinal diseases due to the increased risk of gastrointestinal perforations. Report any unusual symptoms to the doctor immediately. Close monitoring of clinical condition or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

Dosage

  • Missed Dose

    The missed dose should be taken as soon as possible. It is advisable to skip the missed dose if it is already time for your next scheduled dose. Do not use extra medicine to make up for the missed dose.

  • Overdose

    Seek emergency medical treatment or contact the doctor in case of an overdose.

Interactions

Interaction with Medicines
  • Atazanavir moderate
  • Ciprofloxacin moderate
  • Carbamazepine moderate
  • Clarithromycin moderate
  • Lansoprazole severe
  • Pantoprazole severe
  • Fluvoxamine moderate
Disease interactions
  • severe

    This medicine should be used with extreme caution in patients suffering from gastrointestinal diseases such as peptic ulcer disease and diverticular disease due to the increased risk of worsening of the patient's condition. Close monitoring of clinical condition, appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.This medicine should be used with extreme caution in patients suffering from gastrointestinal diseases such as peptic ulcer disease and diverticular disease due to the increased risk of worsening of the patient's condition. Close monitoring of clinical condition, appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

  • severe

    This medicine should be used with extreme caution in patients suffering from eye diseases such as primary keratitis, ulcerative keratitis, conjunctivitis, etc. due to an increase in the risk of worsening of the patient's condition. Report any unusual symptoms or worsening of eye symptoms to the doctor immediately. Close monitoring of clinical condition or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

  • severe

    This medicine should be used with caution in patients with a history of kidney diseases due to the increased risk of severe adverse effects. Close monitoring of kidney function, appropriate dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition of the patient.

  • severe

    This medicine should be used with extreme caution in patients suffering from liver diseases due to the increased risk of worsening of the patient's condition. Close monitoring of liver function is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition of the patient.

Food interactions
  • Consumption of grapefruit juice is not recommended during treatment with this medicine due to the increased risk of severe adverse effects such as nausea, vomiting, diarrhea, etc.

General Instructions

Consumption of grapefruit juice is not recommended during treatment with this medicine due to the increased risk of severe adverse effects such as nausea, vomiting, diarrhea, etc.

Other details

  • To be taken on an empty stomach
  • To be taken as instructed by doctor
  • Effect on sleep is not established

References

Additional Information:

what are the adverse effects of Erlocip tablet 150 mg 30’s?

Fatigue, rash, alopecia, chest pain, diarrhoea, anorexia, nausea, decreased appetite, vomiting, weakness, dyspnoea, cough, infection, pain, headache, increased bilirubin, musculoskeletal pain.

What happens if I miss a dose of Erlocip tablet 150 mg 30’s?

Non-small cell lung cancer: Adults: 150 mg 1 hr before or 2 hr after the ingestion of food.

One of the following licensed pharmacy from the nearest location will deliver Erlocip tablet 150 mg 30’s. The details of the licensed pharmacy shall be shared once you request the drugs and the respective pharmacy accepts your request based on valid prescription and availability.

Want to share this information?
Facebook
Twitter
LinkedIn
Something doesn't feel right ?

Questions and Answers

There are no questions yet. Be the first to ask a question about this product.

Only registered users are eligible to enter questions

Reviews

There are no reviews yet.

Be the first to review “Erlocip tablet 150 mg 30’s”
Shopping Cart